–12 By coupling Apts with PLGA microspheres, we aim to achieve sustained and controlled delivery of Toc directly to CD34+ orbital fibroblasts, thereby enhancing therapeutic efficacy, minimizing systemic side effects, and improving clinical outcomes in patients with TAO by attenuating inflammation and fibrosis. This evidence concerns the gene CD34 and thromboangiitis obliterans.